Literature DB >> 2253029

Differential acute influence of medial and lateral preoptic areas on sleep-wakefulness in freely moving rats.

M N Alam1, B N Mallick.   

Abstract

The role of preoptic area (POA) in sleep-wakefulness and related EEG changes is well established. Anatomically the area is divided into medial (mPOA) and lateral (IPOA) portions having different physiological functions. Knowledge regarding the differential role, if any, of those two areas in sleep and wakefulness was lacking in the literature. Therefore, an attempt was made in this study, to investigate the same systematically. Experiments were conducted during day and night in freely moving rats. Electrophysiological parameters defining sleep and wakefulness were recorded before and after reversible inactivation of those two areas separately by microinjection of a local anaesthetic, marcain. The responses were opposite in nature depending upon the time, day or night, when the anaesthetic was applied. During the day, anaesthetization induced wakefulness while during the night, sleep was precipitated. However, anaesthetization of both the areas though induced similar qualitative response, the degree of the responses differed significantly. The results suggest that the mPOA is more effective in maintaining tonic sleep while the IPOA is more potent in the maintenance of tonic wakefulness in the normal rats. The finding supports and fits well with the existing knowledge.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253029     DOI: 10.1016/0006-8993(90)90870-h

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  The effects of dopamine D(1) receptor blockade in the prelimbic-infralimbic areas on behavioral flexibility.

Authors:  Michael E Ragozzino
Journal:  Learn Mem       Date:  2002 Jan-Feb       Impact factor: 2.460

2.  Nitric oxide production in the perifornical-lateral hypothalamic area and its influences on the modulation of perifornical-lateral hypothalamic area neurons.

Authors:  A Kostin; S Rai; S Kumar; R Szymusiak; D McGinty; M N Alam
Journal:  Neuroscience       Date:  2011-01-28       Impact factor: 3.590

3.  Sleep-waking discharge patterns of median preoptic nucleus neurons in rats.

Authors:  Natalia Suntsova; Ronald Szymusiak; Md Noor Alam; Ruben Guzman-Marin; Dennis McGinty
Journal:  J Physiol       Date:  2002-09-01       Impact factor: 5.182

4.  The role of the medial preoptic area of the hypothalamus in organizing the paradoxical phase of sleep.

Authors:  N V Suntsova; O Yu Dergacheva
Journal:  Neurosci Behav Physiol       Date:  2004-01

5.  GABA-mediated control of hypocretin- but not melanin-concentrating hormone-immunoreactive neurones during sleep in rats.

Authors:  Md Noor Alam; Sunil Kumar; Tariq Bashir; Natalia Suntsova; Melvi M Methippara; Ronald Szymusiak; Dennis McGinty
Journal:  J Physiol       Date:  2004-12-21       Impact factor: 5.182

6.  Repeated microinjections into the medial prefrontal cortex (mPFC) impair extinction of conditioned place preference in mice.

Authors:  Peter A Groblewski; Christopher L Cunningham
Journal:  Behav Brain Res       Date:  2012-02-08       Impact factor: 3.332

7.  Role of adenosine A(1) receptor in the perifornical-lateral hypothalamic area in sleep-wake regulation in rats.

Authors:  Md Noor Alam; Sunil Kumar; Seema Rai; Melvi Methippara; Ronald Szymusiak; Dennis McGinty
Journal:  Brain Res       Date:  2009-09-23       Impact factor: 3.252

8.  Efferent projections of excitatory and inhibitory preBötzinger Complex neurons.

Authors:  Cindy F Yang; Jack L Feldman
Journal:  J Comp Neurol       Date:  2018-03-09       Impact factor: 3.215

9.  Glutamatergic Neurons in the Preoptic Hypothalamus Promote Wakefulness, Destabilize NREM Sleep, Suppress REM Sleep, and Regulate Cortical Dynamics.

Authors:  Alejandra Mondino; Viviane S Hambrecht-Wiedbusch; Duan Li; A Kane York; Dinesh Pal; Joaquin González; Pablo Torterolo; George A Mashour; Giancarlo Vanini
Journal:  J Neurosci       Date:  2021-03-04       Impact factor: 6.709

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.